Huperzine A
Huperzine A is an intervention with 8 clinical trials. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Huperzine A in Treatment of Moderate to Severe TBI
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise
Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease
Clinical Trials (8)
Effects of Huperzine A in Treatment of Moderate to Severe TBI
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise
Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease
Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A
Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
Huperzine A in Alzheimer's Disease
All 8 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 8